Page last updated: 2024-11-12
2,7,4'-trihydroxyisoflavanone
Description
2,7,4'-trihydroxyisoflavanone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2,4',7-trihydroxyisoflavanone : A hydroxyisoflavanone that is isoflavanone with hydroxy substituents at positions 2, 7 and 4'. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 11954208 |
CHEBI ID | 52047 |
SCHEMBL ID | 571732 |
MeSH ID | M0379056 |
Synonyms (8)
Synonym |
2,7,4'-trihydroxyisoflavanone |
2,4',7-trihydroxyisoflavanone |
CHEBI:52047 |
2,7-dihydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one |
2,7-dihydroxy-3-(4-hydroxyphenyl)chroman-4-one |
SCHEMBL571732 |
2,7-dihydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one |
Q27123131 |
Drug Classes (2)
Class | Description |
hydroxyisoflavanone | Any member of the class of isoflavanones with at least one hydroxy substituent. |
lactol | Cyclic hemiacetals formed by intramolecular addition of a hydroxy group to an aldehydic or ketonic carbonyl group. They are thus 1-oxacycloalkan-2-ols or unsaturated analogues. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.03
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.03 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.82 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |